Literature DB >> 2073100

Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

K Lazardi1, J A Urbina, W de Souza.   

Abstract

We report the ultrastructural alterations induced during the proliferative stages of Trypanosoma (Schizotrypanum) cruzi, the causative agent of Chagas' disease, by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, which had previously been shown to be potent growth inhibitors whose effects are potentiated when used in combination (J. A. Urbina, K. Lazardi, T. Aguirre, M. M. Piras, and R. Piras, Antimicrob. Agents Chemother. 32:1237-1242, 1988). Epimastigotes treated with a low concentration of ketoconazole (1 microM), which blocks ergosterol biosynthesis at the level of C-14 demethylation of lanosterol and induces cell lysis coincident with total ergosterol depletion, showed gross alterations of the kinetoplast-mitochondrion complex, which swelled and lost the organization of its inner membrane and the electron-dense bodies of its matrix. Thus, coincident with the beginning of cell lysis, the kinetoplast-mitochondrion complex occupied greater than 80% of the cell volume, while other subcellular structures such as the nucleus and subpellicular microtubules were not affected. Terbinafine, which blocks ergosterol synthesis in these cells at the level of squalene synthetase and thus leads to almost immediate arrest of growth at concentrations greater than 1 microM, produced proliferation of glycosomelike bodies, binucleated cells (arrest at cytokinesis), and eventually massive vacuolization. When the drugs were combined, the predominant effect was mitochondrial swelling, which was more drastic and took place earlier than that observed in cells treated with ketoconazole alone. In amastigotes proliferating in Vero cells, ketoconazole at the concentration required to eradicate the parasites (10 nM) produced mitochondrial swelling, the appearance of autophagic vacuoles containing partially degraded subcellular material, and finally a general breakdown of the subcellular structures. Terbinafine at 3 microM induced more limited ultrastructural damage to the amastigotes consistent with increased vacuolization of the cells and the appearance of occasional autophagic vacuoles. When the drugs were used in combination, just 1 nM was required for the total eradication of parasites, the ultrastructural effects were more extensive, and cell disintegration occurred earlier than when any of the drugs was used alone at a much higher concentration. No effect of the drugs on the ultrastructure of the host cells were observed at any of the concentrations tested.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2073100      PMCID: PMC172006          DOI: 10.1128/AAC.34.11.2097

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

Review 1.  Cell biology of Trypanosoma cruzi.

Authors:  W de Souza
Journal:  Int Rev Cytol       Date:  1984

Review 2.  Sterol structure and membrane function.

Authors:  K E Bloch
Journal:  CRC Crit Rev Biochem       Date:  1983

3.  Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans.

Authors:  N S Ryder; G Seidl; P F Troke
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

4.  Effects of ketoconazole on growth and sterol biosynthesis of Leishmania mexicana promastigotes in culture.

Authors:  J D Berman; G G Holz; D H Beach
Journal:  Mol Biochem Parasitol       Date:  1984-05       Impact factor: 1.759

5.  Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection of mice against lethal infection with the organism.

Authors:  R E McCabe; J S Remington; F G Araujo
Journal:  J Infect Dis       Date:  1984-10       Impact factor: 5.226

6.  Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase.

Authors:  G Petranyi; N S Ryder; A Stütz
Journal:  Science       Date:  1984-06-15       Impact factor: 47.728

7.  Ca2+ transport in isolated mitochondrial vesicles from Leishmania braziliensis promastigotes.

Authors:  G Benaim; R Bermudez; J A Urbina
Journal:  Mol Biochem Parasitol       Date:  1990-02       Impact factor: 1.759

8.  Fine-structural alterations in Leishmania tropica within human macrophages exposed to antileishmanial drugs in vitro.

Authors:  S G Langreth; J D Berman; G P Riordan; L S Lee
Journal:  J Protozool       Date:  1983-08

9.  Sterols of ketoconazole-inhibited Leishmania mexicana mexicana promastigotes.

Authors:  L J Goad; G G Holz; D H Beach
Journal:  Mol Biochem Parasitol       Date:  1985-06       Impact factor: 1.759

10.  Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent.

Authors:  N S Ryder
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

View more
  32 in total

1.  Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  J A Urbina; K Lazardi; T Aguirre; M M Piras; R Piras
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Amiodarone inhibits Trypanosoma cruzi infection and promotes cardiac cell recovery with gap junction and cytoskeleton reassembly in vitro.

Authors:  Daniel Adesse; Eduardo Meirelles Azzam; Maria de Nazareth L Meirelles; Julio A Urbina; Luciana R Garzoni
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; Paul W Alexander; Jason H Chaplin; Martine Keenan; Susan A Charman; Catherine J Perez; Michael R Waterman; Eric Chatelain; Galina I Lepesheva
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

4.  Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.

Authors:  R A Maldonado; J Molina; G Payares; J A Urbina
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

5.  Effect of elatol, isolated from red seaweed Laurencia dendroidea, on Leishmania amazonensis.

Authors:  Adriana Oliveira Dos Santos; Phercyles Veiga-Santos; Tânia Ueda-Nakamura; Benedito Prado Dias Filho; Daniela Bueno Sudatti; Everson Miguel Bianco; Renato Crespo Pereira; Celso Vataru Nakamura
Journal:  Mar Drugs       Date:  2010-10-29       Impact factor: 5.118

6.  Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.

Authors:  Silvia Orenes Lorente; Juliany C F Rodrigues; Carmen Jiménez Jiménez; Miranda Joyce-Menekse; Carlos Rodrigues; Simon L Croft; Vanessa Yardley; Kate de Luca-Fradley; Luis M Ruiz-Pérez; Julio Urbina; Wanderley de Souza; Dolores González Pacanowska; Ian H Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

7.  Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.

Authors:  J A Urbina; K Lazardi; E Marchan; G Visbal; T Aguirre; M M Piras; R Piras; R A Maldonado; G Payares; W de Souza
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

8.  CYP51: A major drug target in the cytochrome P450 superfamily.

Authors:  Galina I Lepesheva; Tatyana Y Hargrove; Yuliya Kleshchenko; W David Nes; Fernando Villalta; Michael R Waterman
Journal:  Lipids       Date:  2008-09-04       Impact factor: 1.880

9.  In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects.

Authors:  Juliany Cola Fernandes Rodrigues; Juan Luis Concepcion; Carlos Rodrigues; Aura Caldera; Julio A Urbina; Wanderley de Souza
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

10.  Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.

Authors:  Wanderley de Souza; Juliany Cola Fernandes Rodrigues
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.